Article Details
Retrieved on: 2020-11-22 01:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA said the <b>monoclonal antibodies</b>, casirivimab and imdevimab, should be administered together for the treatment of mild to moderate ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here